New Diagnostic Test for Alzheimer’s Disease Recently Approved
A few forgetful moments can elicit worries about cognitive decline and Alzheimer’s disease in many individuals, especially older adults. What if there were a simple test that could indicate your likelihood of developing Alzheimer’s, allowing you to seek treatment right away? Well, now there is.
The U.S. Food and Drug Administration (FDA) recently approved a blood test that could help doctors diagnose and assess Alzheimer’s disease in patients. Such reliable tests are less invasive than current assessment methods and can yield rapid results that enable patients to begin treatment as soon as possible.
Here are the facts about the latest FDA-approved test and its implications for Alzheimer’s disease treatment. We also highlight the ReCODE Protocol and other integrative dementia and cognitive health treatments available at Blatman Health and Wellness Center.
Facts About the New Blood Test for Alzheimer’s Disease
The FDA approved a new lab blood test that would be part of an initial assessment of Alzheimer’s disease. Roche Diagnostics and Eli Lilly collaborated to develop the test, intended for patients 55 and older or individuals with early signs of cognitive decline.
The blood test measures levels of pTau181, a protein associated with Alzheimer’s disease. In a clinical study, researchers at Roche found that the test had a 97.9% negative predictive value for ruling out Alzheimer’s. This finding implies that if you took the test and it came back negative, there’s more than a 97% chance that you don’t have Alzheimer’s disease.
Hope for People with Alzheimer’s Disease
Early treatment of neurodegenerative conditions is crucial for combating Alzheimer’s and having any possibility of reversing the initial phases of cognitive decline. Unfortunately, more conventional diagnostic measures consist of invasive procedures, such as a spinal tap, and other methods that health insurers don’t cover.
Conversely, the pTau81 test promises to be minimally invasive and yield reliable, quick results. Access to such diagnostic methods can lead to faster diagnoses and more effective treatments, especially at earlier stages of Alzheimer’s disease and other forms of dementia. Furthermore, there are thousands of diagnostic machines in laboratories across the U.S., and they are well-positioned to integrate this latest blood test into their systems.
Holistic Treatment and Support for Cognitive Decline
A timely and accurate diagnosis of Alzheimer’s disease is a crucial step in fighting cognitive deterioration and preserving brain health. Even when Alzheimer’s is not a concern, it’s never too early to take steps to support your brain and keep it healthy as you get older.
Furthermore, medication alone is not sufficient to slow down or halt the decline associated with Alzheimer’s disease. Despite the lack of a cure at this time, we already know a lot about diagnosing and treating cognitive degeneration, even reversing it at early stages. For example, medical experts agree that treating neurodegenerative diseases requires a multifaceted approach. That idea is fundamental to the ReCODE Protocol, available at Blatman Health and Wellness Center.
Developed by Dr. Dale Bredesen, ReCODE is a natural, all-encompassing treatment plan that transforms medicine’s approach to memory care. It’s up to 85% effective in reversing aging-related cognitive decline, especially in early-stage Alzheimer’s.
Dr. Blatman, a board-certified physician in integrative and holistic medicine at Blatman Health and Wellness Center, is qualified to administer the ReCODE Protocol. He acknowledges that there is no single cause of cognitive decline. Instead, many factors contribute to deterioration, including stress, a sedentary lifestyle, nutrition, and others. Therefore, to reverse the decline and even improve cognitive health, the Protocol employs multiple strategies that focus on the following components:
- Detoxification
- Exercise
- Nutrition
- Sleep hygiene
- Supplementation
- Stimulation
- Stress management
- Assessment and correction of cell membrane composition
Each of these strategies alone promotes healing, but when combined, they can boost the brain’s capacity to adapt and grow new neurons in response to new stimuli. That’s why ReCODE is not just beneficial for people with Alzheimer’s but for anyone who wants to support their brain health before age-related problems arise.
Protect Your Brain Health with Proactive Integrative Medical Care
Medicine continues to make significant strides in diagnosing and treating Alzheimer’s disease and other types of age-related cognitive decline. Working with us at Blatman Health and Wellness Center can ensure you get the best care for your brain health and address any issues affecting your cognitive function in its early stages. Contact us today to get answers to all your health questions and schedule your next appointment for a comprehensive cognitive evaluation.
